CD8A and COVID-19: When evaluated as a booster dose following the administration of commercial vaccines against COVID-19 in humans [87], SpiN demonstrated increased IFN-γ production by CD4+ and CD8+ T cells, including memory subsets, in individuals pre-vaccinated with CoronaVac, ChadOx1-S, and BNT162b2.